SCHEMBL1991296

SCHEMBL1991296

C1=Cc2sccc2CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17081015 0.68 PNMT (0.36)
SCHEMBL1650499 0.62
SCHEMBL12099054 0.62
SCHEMBL1650500 0.61
SCHEMBL741045 0.61
SCHEMBL4757718 0.60
SCHEMBL28167488 0.59 PARP1 (0.95)
SCHEMBL206965 0.58
Bromide SCHEMBL19031040 0.58 PARP1 (0.91)
SCHEMBL581338 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1907397-B1 METHOD OF PREPARING CLOPIDOGREL AND INTERMEDIATES USED THEREIN HANMI HOLDINGS CO LTD (KR) 2011-06-29 EP claimed
US-7652140-B2 Method of preparing clopidogrel and intermediates used therein HANMI PHARM. CO., LTD (KR) 2010-01-26 US claimed
EP-1907397-A4 METHOD OF PREPARING CLOPIDOGREL AND INTERMEDIATES USED THEREIN HANMI PHARM IND CO LTD (KR) 2009-05-27 EP claimed
US-20080214821-A1 Method of Preparing Clopidogrel and Intermediates Used Therein HANMI PHARM., CO., LTD. (KR) 2008-09-04 US claimed
EP-1907397-A1 METHOD OF PREPARING CLOPIDOGREL AND INTERMEDIATES USED THEREIN Hanmi Pharm. Co., Ltd. (KR) 2008-04-09 EP claimed
WO-2006137628-A1 METHOD OF PREPARING CLOPIDOGREL AND INTERMEDIATES USED THEREIN HANMI PHARM. CO., LTD. (KR) 2006-12-28 WO claimed
US-12162890-B2 Heteroaromatic NMDA receptor modulators and uses thereof NOVARTIS AG (CH) 2024-12-10 US disclosed
US-20230128889-A1 REL/RELA/SPOT SMALL MOLECULES MODULATORS AND SCREENING METHODS Université Libre de Bruxelles (BE) 2023-04-27 US disclosed
US-20230023543-A1 HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF NOVARTIS AG (CH) 2023-01-26 US disclosed
WO-2021197574-A1 REL/RELA/SPOT SMALL MOLECULES MODULATORS AND SCREENING METHODS Université Libre de Bruxelles (BE) 2021-10-07 WO disclosed
EP-1684787-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2014-04-16 EP disclosed
EP-1907397-B1 METHOD OF PREPARING CLOPIDOGREL AND INTERMEDIATES USED THEREIN HANMI HOLDINGS CO LTD (KR) 2011-06-29 EP disclosed
US-7763730-B2 Method preparation clopidogrel and intermediates used therein HANMI PHARM. CO., LTD (KR) 2010-07-27 US disclosed
US-7557101-B2 4,5,6,7-tetrahydro-thieno[3,2-c] pyridine derivatives HOFFMAN-LA ROCHE INC. (US) 2009-07-07 US disclosed
EP-1907397-A4 METHOD OF PREPARING CLOPIDOGREL AND INTERMEDIATES USED THEREIN HANMI PHARM IND CO LTD (KR) 2009-05-27 EP disclosed
US-20080214821-A1 Method of Preparing Clopidogrel and Intermediates Used Therein HANMI PHARM., CO., LTD. (KR) 2008-09-04 US disclosed
US-20080146558-A1 4,5,6,7-Tetrahydro-Thieno [3,2-C] Pyridine Derivatives HOFFMANN-LA ROCHE, INC. 2008-06-19 US disclosed
EP-1907397-A1 METHOD OF PREPARING CLOPIDOGREL AND INTERMEDIATES USED THEREIN Hanmi Pharm. Co., Ltd. (KR) 2008-04-09 EP disclosed
WO-2006137628-A1 METHOD OF PREPARING CLOPIDOGREL AND INTERMEDIATES USED THEREIN HANMI PHARM. CO., LTD. (KR) 2006-12-28 WO disclosed
EP-0785205-B1 2-SILYLOXYTETRAHYDROTHIENOPYRIDINE, SALT THEREOF, AND PROCESS FOR PRODUCING THE SAME UBE INDUSTRIES (JP) 2002-04-17 EP disclosed